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Abstract
During differentiation, neurons progressively restrict their fate repressing the expression of specific genes. Here we describe
the involvement in such developmental steps of the methyl-CpG binding protein 2 (MeCP2), an epigenetic factor that
participates to chromatin folding and transcriptional regulation. We previously reported that, due to transcriptional
impairments, the maturation of Mecp2 null neurons is delayed. To evaluate whether this could stem from altered
progenitors proliferation and differentiation, we investigated whether lack of Mecp2 affects these features both in vitro and
in vivo. We show that in Mecp2 null embryonic cortexes the expression of genes defining the identity of proliferating
neuroprogenitors is enriched and that their permanence in the G1 phase is prolonged. Moreover, the number of cells
transitioning from a stage of maturation to a more mature one is increased in Mecp2 null embryonic cortices, in line with
the central role of G1 for cell identity refinement. We thus suggest that, possibly due to the lack of proper transcriptional
control normally exerted by Mecp2, fate refinement is impaired in developing null cells. We propose that the maturation
delay affecting the developing Mecp2 null cortex originates, at least in part, from deranged mechanisms of cell fate
refinement.
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Introduction
Mutations of the X chromosome linked gene MECP2 generate a
plethora of different neurological disorders within which Rett
syndrome (RTT) is the most strongly correlated (Amir et al.
1999; Tsankova et al. 2007; Diaz de Leon-Guerrero et al. 2011;
Piton et al. 2011). RTT is a neurodevelopmental disease that
affects mostly females; the onset of overt clinical symptoms is
typically delayed and the pathology becomes evident after an
initial early postnatal phase that has long been considered nor-
mal. Due to this feature, the field of RTT studies mostly investi-
gated the roles played by methyl-CpG binding protein 2
(MeCP2) in adulthood (Pohodich and Zoghbi 2015). However,
many studies now demonstrate that MeCP2 functions are
important also during neuronal maturation. In fact, according
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to retrospective analyses observations collected during the first
few months of presymptomatic phase, RTT patients already
display several subtle behavioral abnormalities (Nomura 2005;
Fehr et al. 2011). Moreover, reduced occipitofrontal circumfer-
ence, length, and weight are already present at birth (Huppke
et al. 2003). Furthermore, the very rare cases of RTT male
patients usually manifest harsh signs of neurological dysfunc-
tion already at birth, suggesting the onset of abnormalities
already during embryonic development (Smeets et al. 2012).
Interestingly, Mecp2 animal models display structural and func-
tional defects well before the overt symptomatic phase arises
(Dani et al. 2005; Picker et al. 2006; Chao et al. 2007; Baj et al.
2014). Based on such indications, a new trend in MeCP2 studies
is now analyzing its role during in vitro differentiation of stem
cells (embryonic stem cells, neuronal stem cells, induced plu-
ripotent stem cells). Such studies demonstrate that in vitro dif-
ferentiated newborn null neurons display defects that largely
overlap with features typically displayed by adult null neurons
(Tsujimura et al. 2009; Marchetto et al. 2010; Okabe et al. 2010;
Kim et al. 2011; Tanaka et al. 2014; Djuric et al. 2015).
Accordingly, we have recently demonstrated that in vivo early
differentiation is also altered, as the transcriptional profile of
the E15.5 Mecp2 null cortexes already display a decreased
expression of genes defining the postmitotic identity of cortical
glutamatergic neurons (Bedogni et al. 2016).
Taken together, these data suggest that MeCP2 concurs to
early neuronal maturation and feasibly plays a role during the
first phases of neurogenesis, when neural progenitor cells
(NPCs) are proliferating and early neurons are being produced.
Supporting this hypothesis, short interfering RNAs directed
towards MECP2 hamper proliferation in a number of non-
neuronal cell types such as glial cells (Nagai et al. 2005), pros-
tate cells and cancer prostate cells (Bernard et al. 2006), NIH/
3T3 (Babbio et al. 2012), MEF and MRC5 (Bergo et al. 2015). Li
and colleagues showed that Mecp2 plays a role also in the pro-
liferation of neuronal precursors in adulthood. Mutation of the
phosphorylation site S421 in fact reduces proliferation and
increases differentiation of adult NPCs, thus, affecting the
mechanisms that shape the fate they acquire (Li et al. 2014).
Moreover, Mecp2 overexpression in the neural tube of chick
embryos reduces the number of cycling cells while driving the
premature differentiation of neurons ectopically positioned close
to the ventricle (Petazzi et al. 2014). Finally, our transcriptional
analysis of E15.5 cortexes showed that, beside the reduced
expression of postmitotic genes, Mecp2 null embryonic cortexes
display increased levels of transcripts usually expressed by pro-
genitors and early postmitotic neurons (Bedogni et al. 2016).
These last results constitute the rationale of the present study. In
Bedogni et al. (2016) we mostly focused on postmitotic matura-
tion; in the present work, we investigate, in vitro and in vivo,
whether cell cycle dynamics and cell fate decision are affected in
Mecp2 null NPCs. Our data suggest that, during neuronal differen-
tiation, lack ofMecp2 protracts the expression of genes that would
normally be withdrawn to enable the refinement of the subse-
quent differentiation steps.
Materials and Methods
Animals and Tissues
The Mecp2 mouse strain was purchased from Jackson
Laboratories (B6.129P2(C)-Mecp2<tm1.1Bird>/J) and transferred to a
CD1 background (Cobolli Gigli et al. 2016). Genotypes were
assessed as already described (Cobolli Gigli et al. 2016).
Time pregnant females were generated by crossing wild
type (wt) males with Mecp2 heterozygous (−/+) females, the day
of vaginal plug was considered E0.5; embryos were then col-
lected from anesthetized (Avertin, Sigma Aldrich) pregnant
females. Embryos dedicated to histology were perfused with 4%
paraformaldehyde (PFA) under a dissection microscope, post
fixed for 4 h, cryoprotected at 4 °C in 30% sucrose, embedded in
optimal cutting temperature (OCT) and sectioned in 12 μm fro-
zen sections. Alternatively, embryos were fixed for 3 h at room
temperature in 70% ethanol, 20% chloroform, 10% acetic acid,
transferred in 100% ethanol, paraffin embedded and cut into
8 μm thick sections.
Time pregnant females were intraperitoneally injected at
E15.5 with 5-ethynyl-2′-deoxyuridine (EdU; 30mg/kg); embryos
were collected 1 h later.
Ai27-NeuroD6-CRE double positive male mice (Jackson
Laboratory) (Goebbels et al. 2006) were crossed with Mecp2 het-
erozygous females to generate Mecp2 null and wt mice expres-
sing tdTomato in neurons.
All procedures were performed in accordance with the
European Community Council Directive 86/609/EEC for care and
use of experimental animals; all the protocols were approved
by the Italian Minister for Scientific Research and by the local
Animal Care Committee.
Neurospheres Generation
The generation of E15.5 NPCs cultures was described in Gritti
et al. (1996). Briefly, dissected cortexes were transferred in
Dulbecco’s Modified Eagle Medium/F12 (DMEM/F12) and dissoci-
ated with Papaine (Sigma) and DNase (Roche). Cells were then
grown in complete medium: DMEM/F12, 0.66% glucose, 2mM
L-glutamine, 1× Pen/Strep, 4 ng/ml heparin, hormone mix
(DMEM/F12, glucose 0.06%, insulin 25 μg/ml, putrescine 9.7 μg/
ml, apotransferrin 0.1mg/ml, sodium selenite 0.03 μM, proges-
teron 0.02 μM), 20 ng/ml epidermal growth factor (EGF), 10 ng/ml
basic fibroblast growth factor (bFGF); all such reagents were
purchased from Sigma or Peprotech (EGF and bFGF). Spontane-
ously formed neurospheres were then dissociated in single cell
cultures, plated on matrigel-coated coverslips and fixed with
4% PFA for microscopy.
For the 5-bromo-2′deoxyuridine (BrdU) incorporation assay,
BrdU (10 μM, Sigma) was added to the culture every 2 h (for
14 h), at least 3 slides were collected 30min after each
administration.
For the neurospheres generation assay 5000 single cells
were resuspended in 100 μl of complete medium in each well of
a 96-well plate; the day of plating was considered DIV0. At DIV3
and 7 the generation of spheres was evaluated using an IN-Cell
Analyzer 1000 System (GE Healthcare).
Histology, Immunofluorescence, and
Immunohistochemistry
Mounted sections were washed in PBS and PBST (0.01%
Tween20, Sigma) and incubated for 1 h in blocking solution
(10% horse serum, 0.1% TritonX-100, PBS). When needed, anti-
gen retrieval was achieved by heat treating in 0.01M sodium
citrate buffer (pH 6.4) and washing for 30min in 0.1M glycine
(Sigma). BrdU detection required the incubation in 1 N chloric
acid at 37 °C for 30min. Tissues were then incubated overnight
at 4 °C with the primary antibody diluted in blocking solution.
Figure S1 describes primary antibodies concentrations and
whether antigen retrieval was used. Slides were then thoroughly
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washed in PBS, incubated for 1 h in Alexafluor secondary anti-
bodies (Molecular Probes; 1:500 in blocking solution). For bright
field imaging, biotinylated secondary antibody (Vector
Laboratory) incubation was followed by signal amplification
(ABC kit, Vector Laboratory); VIP peroxidase substrate (Vector
Laboratory) was then used to produce the staining. Slides were
mounted in Fluoromount-G (eBioscience) after incubation in
DAPI (Invitrogen) and PBS washings. Tissues fixed in ethanol
were handled in the same way after rehydration in xylene and
decreasing ethanol solutions (100%, 75%, 50%). EdU detection
required the Click-iT EdU Alexa Fluor 555 Imaging Kit.
Imaging was based on either a Leica TCS SP5 laser scanning
confocal microscope (for histology) or a Zeiss Axio Imager II
fluorescent widefield microscope (for cytological assessments).
Cells were counted within bins of 50 μm × 330 μm by an investi-
gator blinded to the experimental groups. Adobe Photoshop
was used to either keep track of cell counts or build the panels
for each regular and Supplementary figure. CyclinD1 intensity
assessments required setting 3 different levels of threshold
(weak, intermediate, strong; ImageJ) and manual counting.
Dotted PCNA cells were counted applying a mask that automat-
ically highlighted highly intense pixels (dots); cells containing
dots were then manually counted. The number of single posi-
tive cells in Figure 4 refers to the number of cells expressing
the single marker (Pax6, Tbr2) minus the number of cells
expressing both markers (Pax6/Tbr2).
Two-way ANOVA comparing the distribution in each bin
and the genotypes as variables and their interaction was used
to analyze the statistical significance of our counts. Post hoc
analysis, when needed, were based on Bonferroni’s test, the
confidence interval threshold (a) was set at 0.05. Values for
each statistical assessment are described in figure legends.
Cell Sorting, RNA Purification, cDNA Synthesis, and
Quantitative PCR
TdTomato positive embryos were produced by crossing Ai27 pos-
itive animals with NeuroD6 CRE drivers (Goebbels et al. 2006);
recombination events were comparable in wt and Mecp2 null
animals (Fig. S2). Tissues were dissected in HBSS and genotyped.
Tissues were digested with Papaine (Sigma) and DNAse (Roche);
cells were then sorted using FACSAria II (BD Bioscience) and col-
lected in RNA later (Ambion). RNA was purified from TdTomato
positive and negative wt and Mecp2 null E15.5 embryos using the
Nucleospin RNA XS RNA purification kit (Macherey-Nagel), eluted
in 10 μl RNA/DNAse free H2O and quality checked using a
Bioanalyzer RNA 6000 Nano chips (Agilent). For qPCR experi-
ments, 50ng of total RNA were reverse-transcribed using
Superscript IV Reverse Transcriptase (Thermo Fisher). For each
sample, 1 ng of cDNA was preamplified using a 0.2X pool of 32
primers (TaqMan; including housekeeping, see Fig. S3) for 18
cycles using PreAmp Master Mix (Fluidigm) to enable multiplex
sequence-specific amplification of targets. Preamplified cDNA
was then diluted and assessed using the 96 × 96 qPCR
DynamicArray microfluidic chips (Fluidigm) following the manu-
facturer’s instructions. Baseline correction was set on Linear
(Derivative), Ct Threshold Method was set on Auto (global) and
Ct calculations were then elaborated in Excel (Microsoft). To nor-
malize Ct, the stability of different housekeeping genes was cal-
culated (NormFinder). All the values ranged between 0.010 and
0.018; PPia (0.016) was chosen as normalizer of all the transcrip-
tional assessments.
Gene Set Enrichment Analysis
The gene set enrichment analysis (GSEA) (Subramanian et al.
2005) was performed on already published microarray data
(Bedogni et al. 2016). We superimposed on this dataset 2 cus-
tom made gene-sets representing apical and basal progenitors
(AP and BP) (Fig. S5) designed according to Telley et al. (2016).
Results
We previously demonstrated that embryonic cortexes lacking
Mecp2 display increased levels of proliferative genes and, com-
plementary, reduced expression of postmitotic transcripts, a
phenotype that we interpreted as driven by a delay in matura-
tion (Bedogni et al. 2016). Given that the acquirement of proper
neuronal features and the establishment of mature cortical
networks strictly depend on the dynamics of neuroprogenitors
(NPCs) proliferation (Arai and Pierani 2014), we analyzed such
dynamics in deeper details.
To this aim, we at first used in vitro cultures of cortical NPCs
generated from E15.5 embryonic cortex. NPCs spontaneously
proliferate forming neurospheres when cultured in the presence
of mitogens (EGF and bFGF), (Gritti et al. 1996). Size and number
of Mecp2 null neurospheres in Mecp2 null samples were compa-
rable to controls at both early (day in vitro 3; DIV3) and late (DIV
7) stages of growth, in line with a previous study performing
this analysis at DIV9 (Kishi and Macklis 2004) (Fig. 1A,B). This is
in accordance with previous reports proposing that Mecp2 defi-
ciency does not compromise neurogenesis; many studies in fact
point out that the number of neurons populating the adult
Mecp2 null cortex is comparable to wt (Chen et al. 2001; Guy
et al. 2001; Kishi and Macklis 2004). However, with this approach
we could not exclude subtle alterations in the cell cycle dynam-
ics. To further assess whether cell cycle progression of Mecp2
null NPCs could be affected, we analyzed the rate of BrdU incor-
poration within a short time window. To avoid any influence
driven by disparities in cell density, we plated cortical progeni-
tors obtained from Mecp2 heterozygous females. Given Mecp2 is
an X chromosome linked gene, in heterozygote samples, after
random X chromosome inactivation, each cell expresses either
the wt or the Mecp2 null allele. The expression of Mecp2 was
assessed post hoc using a specific antibody (Fig. 1C). Plated NPCs
were cultured in proliferating conditions, BrdU (10 μM) was
added every 2 h and samples were collected 30min after each
BrdU administration (Fig. 1D). The experiment lasted 14.5 h,
thus less than an entire cell cycle (Takahashi et al. 1995). In line
with the neurosphere formation assay, both Mecp2 positive and
negative cells reached a plateau stage, implying that both types
of cells eventually entered cell cycle. However, 2.5 h after the
first BrdU addition, the proportion of negative cells incorporat-
ing BrdU was reduced by roughly 20%, suggesting that Mecp2
absence reduces the number of cells in S phase.
A possible drawback of these in vitro assessments might be
the lack of extracellular cues participating to the regulation of
cell cycle progression; we thus assessed cell cycle progression
in vivo. To identify the proliferative compartment, we per-
formed immunostainings of cortices at E15.5 using specific
antibodies. As depicted in Figure S4, cells positive for specific
cell cycle antigens were counted in the innermost bins of the
grid we used to subdivide the cortical thickness (see Materials
and Methods for details). To identify the bins corresponding to
the proliferative compartment we evaluated, in wt conditions,
the position of cells expressing the pan cell cycle related protein
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Ki67 (Fig. S4A, C; Turrero Garcia et al. 2016) which were abundant
in the first 2 bins, slightly reduced in bins 3 and 4 and only rarely
detected in bins 5 and 6 that are mostly populated by cells expres-
sing the neuronal marker NeuN (Mullen et al. 1992). Bins 1–4 thus
coincide with the proliferative compartment and were therefore
the main focus of cell cycle dynamic assessments.
To assess S phase, E15.5 pregnant Mecp2 heterozygote
females were injected with EdU (30mg/kg, Fig. 2A) 1 h before
embryos collection and the number of positive cells was
counted in wt and Mecp2 null male embryos. As depicted in
Figure 2D, the number of EdU positive cells in null cortexes was
similar to that of wt samples as overall number and within
each bin. The progression through the subsequent cell cycle
phases was assessed discriminating between dotted or solid
phospho-histone H3 (PH3) staining to recognize cells in G2 or M
phase, respectively (Hendzel et al. 1997; Van Hooser et al. 1998).
Our counts did not highlight any variation in the number of
positive cells (Fig. 2E,F). We thus concluded that the progres-
sion of null progenitors through S, G2, and M phases resulted
for the most part unaffected.
We completed this analysis by considering the transition
through G1 using CyclinD1 (Baldin et al. 1993). In line with the
fact that the length of the G1 phase at E15.5 is much larger
compared with the others (Takahashi et al. 1995; Arai et al.
2011), CyclinD1 positive cells were more abundant compared
with those transitioning through S, G2, and M in both wt and
Mecp2 null samples (Fig. 2C,G). Although our counts did not
reveal any difference in the total number of CyclinD1 positive
progenitors populating the wt or the null cortexes (Fig. 2G), the
analysis of the number of positive cells in each bin revealed
particularly intriguing, as two-way ANOVA revealed a P value
of 0.037 for the interaction between genotypes and bins subdi-
vision. Moreover, a significantly increased number of CyclinD1
positive cells (P value of 0.0208, Bonferroni post hoc test; Fig. 2G′)
was detected in bin 3, an area that roughly coincides with the
subventricular zone (SVZ; as in Fig. S4A, E). Based on this evi-
dence, we next proceeded with a more detailed analysis of the
G1 phase. As depicted in Figure 2C, the intensity of CyclinD1
signal varied from cell to cell regardless their positioning within
the proliferative compartment. It was in fact possible to set
thresholds to recognize cells expressing strong, intermediate or
weak levels of it (Fig. 3A), which in wt samples represented the
13%, 40%, and 46% (standard deviation: ±3.08, ±2.88, and ±4.58,
respectively) over the total counted. Intriguingly, we detected a
significant increased number of weakly CyclinD1 positive cells in
bins 2, 3, and 4 (Fig. 3B; two-way ANOVA followed by
Bonferroni’s post hoc test). The levels of CyclinD1 are important
for S phase entrance, as CyclinD1 overexpression shortens the
length of the G1 phase (Lange et al. 2009), while its inhibition
slows G1/S transition (Calegari and Huttner 2003; Cremisi et al.
2003), thus implying that high levels of CyclinD1 are expressed
by cells approaching the S phase. In line with this, our data dem-
onstrated that in wt animals, cells exiting the M phase and
entering in the G1 phase (recognized through solid PH3 and
CyclinD1 double expression, Fig. 3C) express intermediate or
weak levels of CyclinD1, as quantified in Figure 3D. Moreover, as
predicted, cells entering the S phase (recognized by a dotted
PCNA staining typical) (Arai et al. 2011) (Fig. 3E) express higher
levels of CyclinD1 (Fig. 3F), thus in line with the role of high
levels of CyclinD1 in driving S phase entrance. Together, this
suggests that, compared with wt, the increased number of Mecp2
null progenitors that express low levels of CyclinD1 likely reside
in G1 for a prolonged amount of time.
Since G1 length is crucial for determining the fate each cell
will acquire (Caviness et al. 2003; Lange et al. 2009), we next
assessed whether the subsequent steps of neuronal differentia-
tion were also affected. Cortical development relies on the
tightly regulated (both in time and space) expression of a num-
ber of markers defining the level of maturity each cell type has
reached (Molyneaux et al. 2007). In particular, Pax6 enables to
recognize APs, thus progenitors that divide either symmetri-
cally to produce 2 Pax6 positive cells or asymmetrically to pro-
duce either a postmitotic newborn neuron or a BP that
expresses Tbr2 (Englund et al. 2005; Hevner et al. 2006; Florio
and Huttner 2014). We focused, again, on the first 4 bins of the
grid, as these cover the entire area in which both Pax6 and Tbr2
Figure 1. Mecp2 concurs, in vitro, to the dynamics of NPCs proliferation. (A, B) Wt and Mecp2 null NPCs, cultivated in vitro in proliferating conditions, produce neuro-
spheres of comparable size at both 3 (A, A″, A″′) and 7 DIV (B, B″, B″′). The number of neurospheres produced is accordingly equal (A′, B′). Values represent the mean
(± standard deviation) of 3 independent determinations; each determination was assessed on a pool of NPCs deriving from at least 3 different Mecp2 null and wt ani-
mals. Statistical analysis: Student’s t test, no significant values. Scale bar: A″, A″′, B″, B″′: 500 μm. (C, D) BrdU was administered each 2 h to heterozygous NPCs, cultured
as an adherent monolayer in proliferating conditions. The percentage of BrdU positive cells (over the total counted) is depicted in C; values represent the mean
(± standard deviation) of 3 different neurosphere preparations. Scale bar: i, ii, iii, iv: 10 μm. The percentage of BrdU stained cells either positive or negative for Mecp2
expression was plotted in D (±standard deviation) and the area under the curve was calculated to assess the statistical significance of the difference in the rate of
BrdU incorporation (D′, Student t-test).
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positive cells are located (Fig. S4A, D, E). In particular, a larger
percentage of Pax6 positive cells populate bins 1 and 2, which
roughly coincides to the ventricular zone (VZ), while the distri-
bution of Tbr2 positive cells is more spread in the 4 bins, with
the majority of positive cells residing in bins 2 and 3 (roughly
coinciding with SVZ). As depicted in Figure 4A′,B′, the total
number of single positive cells expressing either Pax6 or Tbr2
did not differ between E15.5 wt andMecp2 null cortexes. However,
we found an increased number of double positive cells both as
total numbers (Fig. 4D) and within bins (Fig. 4D′; two-way ANOVA
followed by post hoc Bonferroni test). Given Pax6 and Tbr2 are
simultaneously expressed during the transition from one popula-
tion to the other (i.e., from AP to BP), this result suggests that a
larger number of cells transitioning from the apical to the basal
identity populates the Mecp2 null proliferative compartment.
Accordingly, 2 gene-sets defining the AP and BP transcriptional
identity (based on published data, (Telley et al. 2016)) superim-
posed on the transcriptional profile of E15.5 Mecp2 null cortexes
(previously described in Bedogni (Bedogni et al. 2016)) showed
that such identities are both significantly enriched in null sam-
ples compared with wt (Fig. S5A, B, B′).
Next we asked whether Mecp2 absence might also affect the
transcriptional changes occurring during the transition from
the stage of progenitor to that of newborn neurons. Early post-
mitotic cells, in fact, progressively abandon their (obsolete) pro-
genitor identity and, while migrating towards the cortical plate,
refine their neuronal features (Hevner et al. 2006; Molyneaux
et al. 2007).
To study in details the withdrawal of former transcriptional
identities, we thus segregated progenitors and early postmitotic
cells from fully matured neurons. To this aim we used a genetic
approach based on the expression pattern of NeuroD6, a gene
expressed by few cells in the VZ/SVZ and by each postmitotic
neuron in the intermediate zone and the cortical plate (Fig. S6).
Ai27-NeuroD6-CRE double transgenic males, in which tdTomato
(tdT) expression is limited to postmitotic NeuroD6 positive
Figure 2. NPCs populating E15.5 Mecp2 null cortexes normally progress through the S–G2–M phases of the cell cycle while the number of cells residing in the G1 phase
of the cell cycle is increased. (A–C) Representative staining of the different markers used to recognize different cell cycle phases in wt and Mecp2 null samples. Scale
bar in A, B, C: 25 μm. (D–D′) The total number of EdU positive cells, representing cells in the S phase, was not different both between genotypes and in singly taken
bins. Two-way ANOVA: interaction: F = 2.123, P = 0.1023. (E–E′) PH3 staining is dotted during the G2 phase. No changes were detected in either total positive numbers
or within each bin. Two-way ANOVA: interaction: F = 1.018, P = 0.3932. (F–F′) Cells in M phase display a solid PH3 staining. No changes were detected in either total
positive numbers or within each bin. Two-way ANOVA: interaction: F = 0.3002, P = 0.8251. (G–G′) CyclinD1 was used to highlight cells in G1. While total number were
not different (G), the interaction between genotype and bin distribution (two-way ANOVA) was: F = 5.124, P = 0.0037 (G′). For bin 3, the post hoc Bonferroni’s test
P value was 0.0208. Values represent the mean (± standard deviation), n = 16wt, 10 Mecp2 null in D, D′, for all the rest: n = 9wt, 6 Mecp2 null.
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neurons, were crossed toMecp2 heterozygous females to produce
wt and Mecp2 null E15.5 cortexes bearing tdT+ and tdT− cells.
Both these populations were dissected out from E15.5 cortexes,
FACS sorted (based on the fluorescent tdTomato signal) and ana-
lyzed through qPCR. Importantly, we verified that the expression
of NeuroD6 does not change between wt and Mecp2 null samples
in E15.5 total cortical extracts and in both populations of sorted
cells (tdT− and tdT+, Fig. 5A); these results confirm that the num-
ber of generated neurons is not affected by lack of Mecp2 (Kishi
and Macklis 2004). In accordance with the expression pattern of
NeuroD6, its levels were notably higher in the tdT+ population
compared with the tdT− (Fig. 5A). Intriguingly, Figure 5B demon-
strates that some newborn neurons located within the VZ/SVZ
expressing the early neuronal marker Tuj1 are not yet tdT+.
Given that at early stages of postmitotic differentiation the fluo-
rescent signal could be too weak to ensure FACS collection in the
tdT+ pool (due to low expression of NeuroD6 and, consequently,
low activation of CRE), we speculated that the dtT− population
included also cells transitioning from the stage of progenitors to
newborn postmitotic neurons.
Next, we assessed the expression of a panel of genes that
are typical of progenitors, postmitotic neurons or both. All
qPCR amplifications were simultaneously run and normalized
(based on housekeeping genes, see Materials and Methods),
thus enabling to compare the levels of expression of each gene
in the 2 different populations according to its normalized
amplification curve (ΔCt). The Y-axis of Figure 5D shows the
difference in the expression of each gene in the tdT− and tdT+
samples (ΔCt of tdT− minus ΔCt of tdT+): negative values corre-
sponded to genes enriched in tdT−, while genes enriched in
tdT+ had positive values. After ranking on the X-axis each gene
according to such values, genes expressed in progenitors segre-
gated from those of postmitotic neurons from left (higher
expression in tdT−) to right (higher expression in tdT+) (Ayoub
et al. 2011). Accordingly, Mecp2 resides in the middle of these 2
extremes, given its expression is roughly equal in mitotic and
postmitotic cells (Li et al. 2013; Bedogni et al. 2016). Altogether,
these observations validated our sorting strategy.
Figure 5E–E′ refers to the transcriptional levels and pattern
of expression of genes highly enriched in either the VZ/SVZ or
intermediate zone (IZ, as depicted in Fig. S6). Our analysis dem-
onstrated that within such genes, Hes1, Tbr2, Ngn2 (all specifi-
cally expressed by cortical progenitors) resulted significantly
upregulated in the tdT− population of the Mecp2 null samples.
Further, we tested genes expressed by either cells transitioning
from the proliferative identity to the postmitotic one (Rnd2,
NeuroD1) (Hevner et al. 2006; Heng et al. 2008) or postmitotic
cells (NeuN). Compared with wt, their levels in Mecp2 null sam-
ples resulted increased in tdT−, although not in a significant
way in the case of NeuN (P = 0.064). No differences in the
expression levels of the genes analyzed were detected in tdT+
(Fig. 5E′) likely due to the fact that this population is more dif-
ferentiated compared with the one our sorting strategy meant
to enrich.
Figure 3. The number of cells residing in G1 phase is increased in Mecp2 null cortexes. (A) CyclinD1 positive cells were analyzed in wt and Mecp2 null samples accord-
ing to the intensity of the signal (s: strong, i: intermediate, w: weak). (B) Quantitation of CyclinD1 positive cells in wt and Mecp2 null samples according to the signal
intensity. Two-way ANOVA for strong and intermediate stained cells: F: 2.212, P = 0.0977; F: 2.316, P = 0.0865. For weakly stained cells, after two-way ANOVA, the
P values for the variables genotype and bin distribution were 0.0001 and 0.0001, respectively, F = 1.947, P = 0.1335. Bonferroni’s post hoc test revealed that the P values
for bins 2, 3, and 4 were 0.041, 0.0001, and 0.013, respectively. (C, D) CyclinD1 levels were evaluated in PH3 positive cells and quantified in D (± standard deviation;
Student t-test). (E, F) CyclinD1 levels were evaluated in PCNA dotted cells and quantified in H. PCNA dots were evaluated through the use of an imageJ mask that high-
light intense pixels, as depicted in e–e″″ and quantified in F (± standard deviation; Student t-test). Scale bar in a′, a″, c′, e′, e″: 25 μm; a″′, a″″, c″, c″′, e″′, e″″: 5 μm. n =
9wt, 6 Mecp2 null.
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The increased transcription of NeuroD1 is of particular inter-
est, as its expression is limited to a population of cells transi-
tioning from the late phases of the cell cycle to the early steps
of postmitotic maturation. Given our interest for the defects in
the transition from one stage of development to a more mature
one, we further investigated this result by counting the number
of NeuroD1 positive cells in E14.5 wt and Mecp2 null cortices
(Fig. 5F). As depicted in Figure 5G, although the total levels of
NeuroD1 positive cells were increased but not significantly (P =
0.078), the number of positive cells in the third bin (where the
wide majority of positive cells are located) was significantly
increased in Mecp2 null samples compared with wt (130.7 vs.
161.4, standard deviation: ±18.3 and 16.1, respectively, two-way
ANOVA followed by Bonferroni post hoc test). This is in line
with our hypothesis of a delayed progression toward a more
mature stage of differentiation affecting Mecp2 null cortexes.
Discussion
The demonstration that Mecp2 plays a role during embryonic
and early postnatal life has opened a new venue in RTT studies
(Feldman et al. 2016). However, whether Mecp2 is involved in
early phases of NPCs proliferation and differentiation is still an
open question. The present study provides evidence of the
involvement of Mecp2 in such stages, possibly linking impaired
NPCs fate refinement to delayed cortical neurons maturation.
The 6-layered mature cerebral cortex arises from temporally
and spatially regulated processes that begin with the establish-
ment and the expansion of a pool of progenitor cells. Within
this pool, APs express Pax6 and reside in the VZ where they
divide symmetrically to self-regenerate or asymmetrical gener-
ating a new AP and either a newborn neuron or a BP
(Haubensak et al. 2004; Miyata et al. 2004; Noctor et al. 2004).
Figure 4. Mecp2 absence interferes with the transition from one identity, to the subsequent, more mature one. (A) The number of Pax6 positive cells (APs) was
assessed as either total number (A′) or within bins (A″). (B) The number of Tbr2 positive cells (BPs) was assessed as either total number (B′) or within bins (B″).
(C) Double positive cells were counted either as total number (D) or within bins (D′). The total number of double positive cells was significantly increased (D, Student
t-test); two-way ANOVA of the analysis in D′ revealed a F = 2.281 and P = 0.0904. Bonferroni’s post hoc test in bin 2 and 3 revealed P values of 0.0001 and 0.0004,
respectively. (D) Colocalization of Pax6 and Tbr2 in wt and null samples. Values represent the mean (± standard deviation). n = 9wt, 6 Mecp2 null. Scale bar for A, B, C:
25 μm; inserts in D: 10 μm.
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Located in the SVZ, BPs express Tbr2 and symmetrically divide
to generate either 2 new BPs or 2 neurons (Englund et al. 2005;
Florio and Huttner 2014). The establishment of mature projec-
tion neurons thus requires the activation of specific transcrip-
tional programs orchestrating the transition through each step
of neurogenesis (Hevner et al. 2006; Molyneaux et al. 2007;
Telley et al. 2016). Such mechanisms are regulated already at
the level of cell cycle progression, as cells cycling to expand the
progenitor pool have a longer S phase compared with those
generating newborn neurons (Arai et al. 2011). Moreover, G1
progressively lengthens during neurogenesis, enabling cells to
establish their next fate (including whether exiting or re-
entering the cell cycle) by combining intrinsic differentiation
programs with the increasing number of cues from the sur-
rounding environment (Calegari and Huttner 2003; Lange et al.
2009; Hardwick et al. 2015). We show here that a larger number
of CyclinD1 (marker of G1) positive cells populate the Mecp2
null cortexes, thus implying that more cells reside in G1 and
suggesting a delayed commitment. Accordingly, the number of
transitioning cells (Pax6/Tbr2 double positive) is increased in
Figure 5. Genes expressed by either NPCs or cells transitioning to postmitotic stages of maturation are upregulated in null samples. (A) qPCR analyses of NeuroD6
expression in wt and Mecp2 null samples deriving from total cortical extracts (left) and tdT− and tdT+ (right) samples, the relative expression was plotted as percent-
age compared with wt (100%) in the case of total extracts or as 2−ΔCt in the case of the 2 sorted populations. (B) Tuj1 (neuronal marker) expression precedes the
expression of tdTomato in both wt (B′) and null (B″) samples; all postmitotic neurons populating the IZ and the CP abundantly express both Tuj1 and tdT. Scale bars:
B′, B″, c–c″″: 20 μm. (D) Genes expressed by different cortical populations in wt samples were ranked based on the difference obtained by subtracting the value of ΔCt
of tdT+ from the value of the ΔCt of tdT−. (E–E′) The expression level of 5 genes typically expressed by progenitors was evaluated in either tdT− (E) or tdT+ (E′) popula-
tions. Each level was expressed as percentage of Mecp2 null levels compared with wt (100%). Statistical analysis: Student’s t test: *P < 0.05. Values represent the mean
(± standard deviation); n = 8wt, 6 Mecp2 null samples. (F) Pattern of expression of NeuroD1 in wt and Mecp2 null cortexes. Scale bars: 25 μm. (G) Quantitation of
NeuroD1 positive cells within wt and Mecp2 null samples. While the total number of positive cells was almost significantly increased (P = 0.078, t-test), after two-way
ANOVA, the P values for the variables genotype and bin distribution were 0.0191 and <0.0001, respectively. The F and P values for interaction were 1.528 and 0.2239.
Bonferroni post hoc test revealed a significant (P = 0.0187) increased in the number of positive cells in bin 3. Values represent the mean (± standard deviation); data
were produced from a minimum of 5 different determinations per genotype.
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Mecp2 null cortexes. Moreover, in a population that likely con-
tains such cells (tdTomato−) the transcription of some general
markers of either progenitors or cells transitioning towards
postmitotic differentiation is increased in null samples. This
suggests that null cells persistently express genes that, in wt
conditions, would typically be withdrawn to enable fate refine-
ment and maturation.
Epigenetic control of transcription is largely involved during
maturation, when each cell restricts its fate by repressing the
expression of specific genes (MacDonald and Roskams 2009;
MuhChyi et al. 2013). Thus, we propose that the persistent tran-
scription of key neurodevelopmental genes and the consequent
presence of unrefined cellular types in Mecp2 null samples
should be considered under the light of the epigenetic role
MeCP2 plays in repressing transcription (Bedogni et al. 2014;
Lombardi et al. 2015). Supporting this hypothesis, Mecp2
absence affects the phenotypic refinement of newborn neurons
in the adult hippocampal granular zone that shows an
increased number of cells coexpressing Doublecortin (Dcx) and
NeuN in Mecp2 null animals (Smrt et al. 2007). Given NeuN posi-
tive neurons are considerably more mature compared with Dcx
positive, the persistent expression of Dcx suggests a phenotype
that largely overlaps with the one described here.
We are aware that previous studies in adult Mecp2 null tis-
sues predominantly highlighted transcriptional downregula-
tions (Tudor et al. 2002; Kriaucionis et al. 2006; Chahrour et al.
2008; Ben-Shachar et al. 2009; Yazdani et al. 2012; Li et al. 2013);
such unexpected evidence might originate from indirect effects
such as compensatory mechanisms downgrading gene expres-
sion to dump the transcriptional noise driven by the absence of
Mecp2. The levels of linker histone H1 are in fact increased in
Mecp2 null mature neuronal nuclei, likely as part of such com-
pensatory mechanisms (Skene et al. 2010). We thus believe that
the direct transcriptional consequences of Mecp2 deficiency are
more evident at the stage of progenitors or newborn neurons,
when compensatory mechanisms are not yet, or not fully, acti-
vated. However, the persistent expression in null neurons of
genes that would typically be withdrawn in wt samples disap-
pears at later time (Fig. 5E′), when such genes return to normal
levels. Nonetheless, their deregulation during early stages of
postmitotic cell refinement likely concurs to the transcriptional
defects that in a previous study we interpreted as a delay in
maturation (Bedogni et al. 2016). To conclude, we show a new
embryonic role played by Mecp2 during critical steps of cell fate
refinement. In null early born cortical neurons deranged fate
refinement likely concurs to other transcriptional defects that
include the reduced expression of transcripts mediating respon-
siveness to external stimuli and activity (Bedogni et al. 2016).
Given activity is one of the main drivers of neuronal maturation
and network establishment (Spitzer 2006), the integration of
immature neurons in the developing cortical networks would
consequently be further delayed, in line with the typical imma-
turity of adult Mecp2 null neuronal networks (Dani et al. 2005;
Lang et al. 2014). Overall, this study extends our knowledge over
the role of MeCP2 during brain development and reinforces the
rationale of therapeutic strategies promoting neuronal matura-
tion (Tropea et al. 2009). Eventually, deranged mechanisms of
early corticogenesis provide a framework not only for RTT but
also for other neurological disorders originating from MECP2
mutations (Tsankova et al. 2007; Neul 2012; Ernst 2016).
Supplementary Material
Supplementary material is available at Cerebral Cortex online.
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